Skip to ContentSkip to Navigation
How to find us prof. dr. H.V. ("Hans") Hogerzeil


Access to cancer medicines in public hospitals in Mexico: The view of stakeholders

Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico

WHO guide to good prescribing is 25 years old: quo vadis?

Access to essential medicines in 195 countries: A human rights approach to sustainable development

Legislating for universal access to medicines: a rights-based cross-national comparison of UHC laws in 16 countries

The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country-The Case of Mexico

The importance of insulin donations for children in 43 low- and middle-income countries

The right to health as the basis for universal health coverage: A cross-national analysis of national medicines policies of 71 countries

A global accountability mechanism for access to essential medicines

A review of promoting access to medicines in China - problems and recommendations

Read more


Meld je aan voor de CBG Collegedag!

Een derde prik, is dat ethisch? ‘De discussie toont aan hoe oneerlijk we zijn geweest’

Hoe zorgen we ervoor dat het coronavaccin eerlijk wordt verdeeld? - NOS Met het Oog op Morgen